Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  OTC Bulletin Board - Other OTC  >  Fennec Pharmaceuticals Inc       CA31447P1009

FENNEC PHARMACEUTICALS INC
Mes dernières consult.
Most popular
Report
 SummaryChartsNewsCalendarCompanyFinancialsConsensus 
Financials ($)
More Financials
Company
Fennec Pharmaceuticals, Inc. operates as a small stage biotechnology company.It engages in the development of sodium thiosulfate for the prevention of ototoxicity from cisplatin in pediatric patients.The company was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham,... 
More about the company
Latest news on FENNEC PHARMACEUTICALS INC
11/13 Fennec Provides Business Update And Reports Third Quarter 2017 Results
10/16 FENNEC PHARMACEUTICALS : Announces Positive Results From Phase 3 SIOPEL 6 Study ..
10/16 Fennec Announces Positive Results From Phase 3 SIOPEL 6 Study on PEDMARK&trad..
09/14 FENNEC PHARMACEUTICALS INC. (OTCMKTS : FENCF) Files An 8-K Financial Statements ..
09/13 FENNEC PHARMACEUTICALS : IIROC Trade Resumption - FRX
09/13 FENNER : IIROC Trade Resumption - Fennec Pharmaceuticals Inc.
09/13 FENNER : IIROC Trade Halt - Fennec Pharmaceuticals Inc.
09/13 FENNEC PHARMACEUTICALS : IIROC Trading Halt - FRX
08/14 FENNEC PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condi..
08/11 FENNEC PHARMACEUTICALS : Provides Corporate Update and Announces Second Quarter ..
More news
Sector news : Bio Therapeutic Drugs
11/22 U.S. FDA approves first two-drug HIV regimen in win for GSK
11/16 Recovery rally for European stocks leaves oil sector behind
11/13 Poor earnings updates keep European shares at seven-week low
11/13DJNOVARTIS : Vision Drug Shows Positive Results in Phase 3 Trials
11/03 Prosecutors search Metro offices in insider trading probe
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
09/13 Fennec Pharma uplisted to Nasdaq Capital Market today
08/17 Fennec Pharmaceuticals (FENCF) Presents At Wedbush PacGrow Healthcare Confere..
08/11 Fennec Pharmaceuticals reports Q2 results
06/09 Fennec Pharma completes private $7.6M capital raise
05/18 Premarket analyst action - healthcare
Chart FENNEC PHARMACEUTICALS INC
Duration : Period :
Fennec Pharmaceuticals Inc Technical Analysis Chart | CA31447P1009 | 4-Traders
Income Statement Evolution
Consensus
 
Mean consensus
Number of Analysts
Average target price -
Spread / Average Target -100%
Managers
NameTitle
Rostislav C. Raykov Chief Executive Officer & Director
Khalid Islam Chairman
Robert C. Andrade Chief Financial Officer
Chris A. Rallis Independent Director
Adrian J. Haigh Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
FENNEC PHARMACEUTICALS INC313.84%130
GILEAD SCIENCES1.69%95 098
REGENERON PHARMACEUTICALS4.73%41 637
VERTEX PHARMACEUTICALS99.59%37 187
GENMAB4.94%11 692
EXELIXIS, INC.74.72%7 731